- Home
- ROIV vs AGI Comparison
ROIV vs AGI Comparison
Compare ROIV & AGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AGI
- Stock Information
- Founded
- ROIV 2014
- AGI 2003
- Country
- ROIV United Kingdom
- AGI Canada
- Employees
- ROIV N/A
- AGI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AGI Precious Metals
- Sector
- ROIV Health Care
- AGI Basic Materials
- Exchange
- ROIV Nasdaq
- AGI Nasdaq
- Market Cap
- ROIV 8.4B
- AGI 10.8B
- IPO Year
- ROIV N/A
- AGI 1999
- Fundamental
- Price
- ROIV $10.87
- AGI $26.25
- Analyst Decision
- ROIV Buy
- AGI Buy
- Analyst Count
- ROIV 4
- AGI 4
- Target Price
- ROIV $17.50
- AGI $30.38
- AVG Volume (30 Days)
- ROIV 5.2M
- AGI 4.2M
- Earning Date
- ROIV 05-29-2025
- AGI 04-30-2025
- Dividend Yield
- ROIV N/A
- AGI 0.38%
- EPS Growth
- ROIV N/A
- AGI 19.70
- EPS
- ROIV N/A
- AGI 0.62
- Revenue
- ROIV $122,585,000.00
- AGI $1,402,300,000.00
- Revenue This Year
- ROIV N/A
- AGI $30.00
- Revenue Next Year
- ROIV N/A
- AGI $10.74
- P/E Ratio
- ROIV N/A
- AGI $42.64
- Revenue Growth
- ROIV 140.04
- AGI 33.63
- 52 Week Low
- ROIV $8.73
- AGI $15.01
- 52 Week High
- ROIV $13.06
- AGI $31.00
- Technical
- Relative Strength Index (RSI)
- ROIV 51.00
- AGI 50.87
- Support Level
- ROIV $10.58
- AGI $25.55
- Resistance Level
- ROIV $11.07
- AGI $26.29
- Average True Range (ATR)
- ROIV 0.30
- AGI 0.69
- MACD
- ROIV -0.04
- AGI 0.03
- Stochastic Oscillator
- ROIV 30.21
- AGI 70.62
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.